BlackRock’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.6M | Buy |
4,574,537
+65,290
| +1% | +$651K | ﹤0.01% | 2469 |
|
|
2025
Q1 | $26.9M | Buy |
4,509,247
+707,738
| +19% | +$4.23M | ﹤0.01% | 2731 |
|
|
2024
Q4 | $29.2M | Sell |
3,801,509
-81,040
| -2% | -$622K | ﹤0.01% | 2765 |
|
|
2024
Q3 | $39.6M | Buy |
3,882,549
+151,513
| +4% | +$1.55M | ﹤0.01% | 2587 |
|
|
2024
Q2 | $55.4M | Sell |
3,731,036
-383,784
| -9% | -$5.7M | ﹤0.01% | 2319 |
|
|
2024
Q1 | $56.1M | Sell |
4,114,820
-146,925
| -3% | -$2M | ﹤0.01% | 2335 |
|
|
2023
Q4 | $46.7M | Sell |
4,261,745
-789,223
| -16% | -$8.64M | ﹤0.01% | 2470 |
|
|
2023
Q3 | $55.3M | Buy |
5,050,968
+370,774
| +8% | +$4.06M | ﹤0.01% | 2310 |
|
|
2023
Q2 | $62M | Buy |
4,680,194
+216,888
| +5% | +$2.87M | ﹤0.01% | 2316 |
|
|
2023
Q1 | $60.7M | Sell |
4,463,306
-16,115
| -0.4% | -$219K | ﹤0.01% | 2286 |
|
|
2022
Q4 | $87.5M | Buy |
4,479,421
+162,264
| +4% | +$3.17M | ﹤0.01% | 2073 |
|
|
2022
Q3 | $82.2M | Buy |
4,317,157
+595,920
| +16% | +$11.4M | ﹤0.01% | 2078 |
|
|
2022
Q2 | $76.7M | Buy |
3,721,237
+389,924
| +12% | +$8.03M | ﹤0.01% | 2179 |
|
|
2022
Q1 | $107M | Buy |
3,331,313
+1,718,085
| +106% | +$55.3M | ﹤0.01% | 2083 |
|
|
2021
Q4 | $75.1M | Buy |
1,613,228
+54,992
| +4% | +$2.56M | ﹤0.01% | 2368 |
|
|
2021
Q3 | $42.1M | Buy |
1,558,236
+41,498
| +3% | +$1.12M | ﹤0.01% | 2739 |
|
|
2021
Q2 | $38.9M | Sell |
1,516,738
-16,584
| -1% | -$425K | ﹤0.01% | 2822 |
|
|
2021
Q1 | $52.4M | Buy |
1,533,322
+468,576
| +44% | +$16M | ﹤0.01% | 2544 |
|
|
2020
Q4 | $36M | Buy |
1,064,746
+402,336
| +61% | +$13.6M | ﹤0.01% | 2630 |
|
|
2020
Q3 | $16.3M | Buy |
+662,410
| New | +$16.3M | ﹤0.01% | 2907 |
|